Search results
Results from the WOW.Com Content Network
A physical exam of the breast is one of the three tests that is scored that is a part of a triple test score. [12] A clinical breast examination (CBE) is different from a breast self-exam because a CBE is conducted by a physician during an appointment whereas a self-exam is recommend to be conducted monthly by patients at home.
Cardiac markers are used for the diagnosis and risk stratification of patients with chest pain and suspected acute coronary syndrome and for management and prognosis in patients with diseases like acute heart failure. Most of the early markers identified were enzymes, and as a result, the term "cardiac enzymes" is sometimes used. However, not ...
The UpToDate system is an evidence-based clinical resource. It includes a collection of medical and patient information, access to Lexicomp drug monographs and drug-to-drug interactions, and a number of medical calculators. UpToDate is written by over 7,100 physician authors, editors, and peer reviewers. It is available both via the Internet ...
Staging breast cancer is the initial step to help physicians determine the most appropriate course of treatment. As of 2016, guidelines incorporated biologic factors, such as tumor grade, cellular proliferation rate, estrogen and progesterone receptor expression, human epidermal growth factor 2 (HER2) expression, and gene expression profiling into the staging system.
A breast mass, also known as a breast lump, is a localized swelling that feels different from the surrounding tissue. [1] Breast pain , nipple discharge , or skin changes may be present. [ 1 ] Concerning findings include masses that are hard, do not move easily, are of an irregular shape, or are firmly attached to surrounding tissue.
Breast diseases make up a number of conditions. The most common symptoms are a breast mass, breast pain, and nipple discharge. [1] A majority of breast diseases are noncancerous. [2] Although breast disease may be benign, or non-life threatening there remains an associated risk with potentially a higher risk of developing breast cancer later on ...
The impact of different stages on outcome can be appreciated in the following table, taken from patient data in the 2013-2015 period, and using the AJCC 8th edition for staging. [28] It does not show the influence of important additional factors such as estrogen receptor (ER) or HER2/neu receptor status, and does not reflect the impact of newer ...
The system is designed to standardize reporting and is used by medical professionals to communicate a patient's risk of developing breast cancer, particularly for patients with dense breast tissue. The document focuses on patient reports used by medical professionals, not "lay reports" that are provided to patients.